Stocks That Hit 52-Week Lows On Thursday
Portfolio Pulse from Benzinga Insights
On Thursday, 64 companies hit new 52-week lows, with Royalty Pharma being the largest by market cap and Bone Biologics the smallest. Bone Biologics also saw the largest drop, with shares down 54.71%, while Castellum shares bounced back the most, rising 0.0% after hitting a new low.
June 15, 2023 | 6:53 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Bone Biologics hit a new 52-week low of $1.78 on Thursday, with shares down 54.71%.
Bone Biologics hitting a new 52-week low and experiencing a significant drop in share price indicates a strong bearish sentiment in the market, which could lead to further downward pressure on the stock in the short term.
CONFIDENCE 90
IMPORTANCE 50
RELEVANCE 100
NEGATIVE IMPACT
Royalty Pharma hit a new 52-week low of $31.96 on Thursday, down 0.47%.
Royalty Pharma hitting a new 52-week low indicates a bearish sentiment in the market, which could lead to further downward pressure on the stock in the short term.
CONFIDENCE 90
IMPORTANCE 50
RELEVANCE 100
NEUTRAL IMPACT
Castellum shares hit a new 52-week low but bounced back, rising 0.0%.
Castellum shares hitting a new 52-week low but bouncing back with no change indicates a neutral sentiment in the market, which could lead to a stable stock price in the short term.
CONFIDENCE 90
IMPORTANCE 50
RELEVANCE 100